Applicant, as named in the Orange Book

Janssen Pharms

Johnson & Johnson · NYSE: JNJ

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Invokamet Xr on 26 Aug 2029. 8 products with live protection, 10 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Invokamet Xr NDA 205879 · 4 strengths canagliflozin; metformin hydrochloride	canagliflozin; metformin hydrochloride	26 Aug 2029 patent	patent
Invokana NDA 204042 · 2 strengths canagliflozin	canagliflozin	26 Aug 2029 patent	patent
Invokamet NDA 204353 · 4 strengths canagliflozin; metformin hydrochloride	canagliflozin; metformin hydrochloride	6 Jul 2030 patent	patent
Invega Sustenna NDA 022264 · 5 strengths paliperidone palmitate	paliperidone palmitate	26 Jan 2031 patent, carve-out possible	patent, carve-out possible
Xarelto NDA 022406 · 4 strengths rivaroxaban	rivaroxaban	17 Aug 2034 patent	patent
Invega Trinza NDA 207946 · 4 strengths paliperidone palmitate	paliperidone palmitate	5 Apr 2036 patent, carve-out possible	patent, carve-out possible
Spravato NDA 211243 esketamine hydrochloride	esketamine hydrochloride	18 Feb 2040 patent, carve-out possible	patent, carve-out possible
Invega Hafyera NDA 207946 · 2 strengths paliperidone palmitate	paliperidone palmitate	24 Nov 2041 patent, carve-out possible	patent, carve-out possible

Recent events

Ortho Tri-Cyclen · Generic approved · ANDA 220876, Annora PharmaApproved 23 Sep 2026Detected 25 Oct 2026
Invega · Generic approved · ANDA 203279, ApotexApproved 26 Jan 2026Detected 25 Oct 2026
Xarelto · Generic approved · ANDA 208579, ApotexApproved 14 Nov 2025Detected 25 Oct 2026
Xarelto · Generic approved · ANDA 218427, ApotexApproved 2 Mar 2026Detected 25 Oct 2026
Xarelto · Generic approved · ANDA 208557, TaroApproved 7 Oct 2025Detected 25 Oct 2026
Xarelto · Generic approved · ANDA 208546, MsnApproved 24 Oct 2025Detected 25 Oct 2026
Ortho Tri-Cyclen Lo · Generic approved · ANDA 220876, Annora PharmaApproved 23 Sep 2026Detected 25 Oct 2026
Xarelto · Generic approved · ANDA 220874, Mankind PharmaApproved 1 Jul 2026Detected 25 Oct 2026
Invokana · First generic approved · ANDA 210449, ApotexApproved 14 Apr 2026Detected 25 Oct 2026
Invokana · Generic approved · ANDA 210449, ApotexApproved 14 Apr 2026Detected 25 Oct 2026
Invokana · Generic tentatively approved · ANDA 210451, Teva Pharms UsaTentative approval 21 Jul 2026Detected 25 Oct 2026
Xarelto · Generic approved · ANDA 216255, Epic Pharma LlcApproved 19 Aug 2026Detected 25 Oct 2026
Invega · Generic approved · ANDA 205402, PharmazoneApproved 7 May 2026Detected 25 Oct 2026
Xarelto · Generic approved · ANDA 218768, Invagen PharmsApproved 20 Feb 2026Detected 25 Oct 2026
Invokana · Generic tentatively approved · ANDA 210503, Laurus Labs LtdTentative approval 29 Sep 2025Detected 25 Oct 2026
Xarelto · Generic approved · ANDA 218195, LupinApproved 25 Sep 2025Detected 25 Oct 2026
Xarelto · Generic approved · ANDA 208334, Micro LabsApproved 30 Jun 2026Detected 25 Oct 2026
Invokana · Generic approved · ANDA 210386, Aurobindo Pharma LtdApproved 20 Apr 2026Detected 25 Oct 2026

Products without listed protection (10)

Drug	Ingredient	Earliest generic entry	Basis
Concerta NDA 021121 · 4 strengths methylphenidate hydrochloride	methylphenidate hydrochloride	open now no listed protection	no listed protection
Elmiron NDA 020193 pentosan polysulfate sodium	pentosan polysulfate sodium	open now no listed protection	no listed protection
Invega NDA 021999 · 3 strengths paliperidone	paliperidone	open now no listed protection	no listed protection
Risperdal NDA 020272 · 6 strengths risperidone	risperidone	open now no listed protection	no listed protection
Risperdal NDA 020588 risperidone	risperidone	open now no listed protection	no listed protection
Risperdal Consta NDA 021346 · 4 strengths risperidone	risperidone	open now no listed protection	no listed protection
Sporanox NDA 020083 itraconazole	itraconazole	open now no listed protection	no listed protection
Topamax NDA 020505 · 4 strengths topiramate	topiramate	open now no listed protection	no listed protection
Topamax NDA 020844 · 2 strengths topiramate	topiramate	open now no listed protection	no listed protection
Xarelto NDA 215859 rivaroxaban	rivaroxaban	open now no listed protection	no listed protection